Using lavender oil wraps to relieve cough in infants with bronchiolitis
Efficacy of Lavender Essential Oil Chest Wraps in Improving Cough and Respiratory Distress in Infants With Bronchiolitis: a Multicenter Randomized Controlled Trial
This study is testing if using lavender oil wraps can help relieve cough in infants with bronchiolitis better than just standard care alone.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | N/A to 11 Months |
| Sex | All |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 2 sites (Fribourg and 1 other locations) |
| Trial ID | NCT06108648 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to determine the effectiveness of lavender essential oil chest wraps in alleviating cough in infants diagnosed with bronchiolitis, compared to standard care alone. Infants will be randomly assigned to receive either standard care with lavender oil wraps or standard care without the wraps. The study will also assess improvements in breathing difficulties, nighttime awakenings, and the overall impact on parents. The trial is being conducted at two hospitals in Switzerland: the Geneva University Hospital and the Fribourg Cantonal Hospital.
Who should consider this trial
Good fit: Ideal candidates for this study are infants hospitalized with a clinical diagnosis of bronchiolitis.
Not a fit: Patients with underlying respiratory or heart conditions, critically ill infants, or those with skin lesions on the chest may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive method to relieve cough and improve respiratory symptoms in infants with bronchiolitis.
How similar studies have performed: While the use of essential oils in medical treatments is gaining interest, this specific approach has not been widely tested in similar studies, making it a novel investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Bronchiolitis: clinical diagnosis based on the combination of respiratory distress (tachypnea, grunting, nasal flaring, retractions, and/or need for supplementary oxygen) and fine crackles sometimes accompanied by wheezing on auscultation. * Hospitalization. * Written informed consent. Exclusion criteria: * Patients with underlying diseases that impact respiratory or heart function (congenital heart disease, congenital malformation of the lung or airway system and severe chronic lung disease). * More than 3 episodes of bronchiolitis. * Critically ill infants who have an immediate need for intensive care unit (ICU) admission. * Respiratory deterioration needing Continuous positive airway pressure (CPAP) or transfer to ICU during study enrollment. * Atopic dermatitis, eczema or other skin lesions (particularly on the chest). * Oncologic disease. * Premature infants with mild bronchopulmonary dysplasia will not be excluded.
Where this trial is running
Fribourg and 1 other locations
- Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland — Fribourg, Switzerland (Recruiting)
- Children's' Hospital, University Hospital of Geneva, Switzerland — Geneva, Switzerland (Recruiting)
Study contacts
- Study coordinator: Fabiola Stollar, MD, PhD
- Email: Fabiola.stollar@hcuge.ch
- Phone: +41795534380
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.